MedPath
HSA Approval

CHLORSEDYL LINCTUS

SIN02933P

CHLORSEDYL LINCTUS

CHLORSEDYL LINCTUS

May 22, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R05DA20

combinations

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

CHLORPHENIRAMINE MALEATE

4 mg/5 ml

Chlorpheniramine

EPHEDRINE HCl

7.2 mg/5 ml

Ephedrine

CODEINE PHOSPHATE

9 mg/5 ml

Codeine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CHLORSEDYL LINCTUS - HSA Approval | MedPath